Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Cilnidipine's Unique Properties in Hypertension Management

Mechanism of Action and Clinical Implications

  • Conventional dihydropyridine calcium channel blockers, such as clevidipine and nicardipine, are known to cause reflex tachycardia, as noted in clinical guidelines by the European Society of Cardiology 1, 2
  • The European Society of Cardiology consensus statement on personalized treatment of angina specifically mentions that reflex tachycardia is common with short-acting dihydropyridines, highlighting the need for alternative treatments like cilnidipine 3

Special Populations and Considerations

  • For patients requiring calcium channel blockers but at risk from tachycardia, such as those with coronary artery disease, cilnidipine offers an advantage over traditional dihydropyridines, as recommended by the American College of Cardiology 4